Specific inhibition of MMP-2 binding to alphavbeta3 integrin for inhibiting angiogenesis Nov. 26, 2001
Potential development candidates emerging from Panacea's HAAH-targeted oncology program Nov. 23, 2001
Gemin X reports in vivo efficacy for small-molecule, cancer-specific apoptosis inducers Nov. 23, 2001